Delivery Order SPE2DB22D3010-SPE2DB24FP2RM
Award Date
6/24/24
Potential Completion Date
6/25/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the leading pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of Vyvanse 10 mg capsules to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. This firm fixed price delivery order, valued at $3,534.06, has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,000.49 for the supply of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA). The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,978,188 units of Vyvanse 40 mg capsules. The $1,567.08 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency, and has a completion date of June 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract, valued at $5,433.46, is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA). The $1,724.00 firm fixed price delivery order has a completion date of May 17, 2024 and was awarded on May 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Vyvanse 30mg capsules to the Defense Logistics Agency (DLA). The $1,210.36 firm fixed-price contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,724.00 firm fixed price delivery order is for the supply of 100 units of the medication Vyvanse 50 mg capsules. The contract has a completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical under a $2,190.10 delivery order. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support the...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,795.74 for the supply of 100 capsules of the drug Vyvanse 30 mg. The contract has a completion date of February 13, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,567.13 to provide VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of November 27, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary...